Literature DB >> 24998604

Loss of calreticulin function decreases NFκB activity by stabilizing IκB protein.

Hamid Massaeli1, Shahrzad Jalali2, Divya Viswanathan3, Nasrin Mesaeli4.   

Abstract

Transcription factor NFκB is activated by several processes including inflammation, endoplasmic-reticulum (ER) stress, increase in Akt signaling and enhanced proteasomal degradation. Calreticulin (CRT) is an ER Ca(2+)-binding chaperone that regulates many cellular processes. Gene-targeted deletion of CRT has been shown to induce ER stress that is accompanied with a significant increase in the proteasome activity. Loss of CRT function increases the resistance of CRT-deficient (crt-/-) cells to UV- and drug-induced apoptosis. Based on these reports we hypothesized that loss of CRT will activate NFκB signaling thus contributing to enhanced resistance to apoptosis. In contrast to our hypothesis, we observed a significant decrease in the basal transcriptional activity of NFκB in CRT-deficient cells. Treatment with lipopolysaccharide failed to increase the transcriptional activity of NFκB in the crt-/- cells to the same level as in the wt cells. Our data illustrate that the mechanism of decreased NFκB activity in CRT-deficient cells is mediated by a significant increase in IκB protein expression. Furthermore, we showed a significant increase in protein phosphatase 2A activity inhibition which resulted in decreased IκBα protein level in CRT-deficient cells. Based on our data we concluded that loss of CRT increases the stability of IκB protein thus reducing NFκB activity.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calreticulin; IκB; NFκB; Okadaic acid; PP2A

Year:  2014        PMID: 24998604     DOI: 10.1016/j.bbamcr.2014.06.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

Review 1.  Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.

Authors:  Hayandra Ferreira Nanini; Claudio Bernardazzi; Fernando Castro; Heitor Siffert Pereira de Souza
Journal:  World J Gastroenterol       Date:  2018-11-07       Impact factor: 5.742

2.  Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer.

Authors:  Jianwen Ye; Lei Qi; Zhicheng Du; Long Yu; Kunlun Chen; Renfeng Li; Ruo Feng; Wenlong Zhai
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

3.  SILAC-based quantitative proteomics to investigate the eicosanoid associated inflammatory response in activated macrophages.

Authors:  Mary K Doherty; Phillip D Whitfield; Nicole Brace; Ian L Megson; Adriano G Rossi
Journal:  J Inflamm (Lond)       Date:  2022-09-01       Impact factor: 6.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.